Where does NeuroWave Systems Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NeuroWave Systems Inc. ranks #8,649 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NeuroWave Systems Inc. hold?

NeuroWave Systems Inc. holds 37 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is NeuroWave Systems Inc.'s Innovation Score?

NeuroWave Systems Inc. has an Innovation Score of 47.6 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NeuroWave Systems Inc. focus on?

NeuroWave Systems Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 37 patents, ranking #517 of 7,127 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is NeuroWave Systems Inc.'s patent grant rate increasing or decreasing?

NeuroWave Systems Inc.'s recent grant velocity is +36% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for NeuroWave Systems Inc.'s patents?

NeuroWave Systems Inc.'s patents average 17.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NeuroWave Systems Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NeuroWave Systems Inc.

USPTO PatentsView assignee record - 37 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neurowave ranks #8,649 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 10 technology areas.

#8,649
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.6/100): 17.5
avg claims per patent: +36%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8649 · US Corporation #8,649 · 37 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 37 grants
UPPER-Q #8,649/49,997
PHOTO-FINISH Net Entertainment…
CPC-FOCUS A61B · 10 areas
INNOV-PAR 47.6/100
CLAIMS-RICH 17.5 claims/avg
TYPE-USCORP US Corporation
VEL-UP +36% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Net Entertainment Malta Services, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neurowave’s 47.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.6 pts (26%) Velocity 13.3 pts (28%) Breadth 11.2 pts (24%) Claim depth 10.5 pts (22%)

Qualcomm Incorporated · highest

85
Belenos Clean Power… · near

48
Bracco Suisse · near

48
Haldex Brake… · near

48
NeuroWave Systems · this assignee

48
Switch · near

48
3D Lighting… · lowest

7

What this shows Neurowave's Innovation Score is 47.6/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neurowave?

Each dot is one of Neurowave’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neurowave’s own 17.5 claims/patent is ABOVE the 6.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Neurowave vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neurowave's grants concentrate

NeuroWave Systems Inc. is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (8 grants) versus a trough of 1 in 2020. By volume, Neurowave sits between Nexion S.P.A. and Optex Co., Ltd..

Neurowave's three-year grant acceleration

NeuroWave Systems Inc. shows 16 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nexion S P A

37
Nippon Sharyo

37
Nippon Thermostat

37
Net Entertainment…

37
Novan

37
Novavax

37
OCI

37
Optex

37
Neurowave Systems ◀

37

What this shows NeuroWave holds 37 patents at rank #8,651, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NeuroWave

By rank, the assignees closest to #8,651 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in NeuroWave's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for NeuroWave, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), NeuroWave ranks #517 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (48 here).

Bracco Suisse SA 48 Haldex Brake Products AB 48 Belenos Clean Power Holding AG 48 Switch, Ltd. 48

Neurowave's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

NeuroWave Systems Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	5.4%
2016	2	5.4%
2017	2	5.4%
2018	3	8.1%
2019	5	13.5%
2020	1	2.7%
2021	2	5.4%
2022	5	13.5%
2023	3	8.1%
2024	8	21.6%
2025partial year	4	10.8%

Which technologies does NeuroWave Systems Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 37

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 8

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

H04B - Transmission 2

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

NeuroWave Systems Inc.'s patent record in context - here's where to go next.

NeuroWave Systems Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #8,649 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NeuroWave Systems Inc. against Nexion S.P.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.